Beat Neuenschwander1, Michael Branson
1Novartis Pharma AG, Basel, Switzerland. beat.neuenschwander@pharma.novartis.com
High dropout rates in long clinical trials complicate results. This study emphasizes modeling missing data, especially nonignorable missingness, to ensure robust statistical inference and reliable trial conclusions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: